
Get at-home solutions for all your health monitoring needs.
Product Platform
The medical device is designed for use by patients or caretakers in at-home setting. It has a similar form factor as a small glucose sensing device. It contains a reader and a single-use cartridge for each test. Each marker requires the use of a distinctive cartridge as each cartridge is specially designed for optimal performance. The time from test to results is in the range of 2-10 minutes, depending on the specific marker. Test results can be locally displayed and communicated to clinicians through cloud EHR connectivity.
*FemtoDx’s platform is in development and not available for patient use.
Product Platform Features
Patient Use
Designed for use by patients or caretakers in at-home setting with a device as small as a glucose sensor.
Perfect for at-home chronic conditions monitoring.
Time to result varies from 2 to 10 minutes, depending on the marker.
Results substantially equivalent to central lab instruments (such as Roche Cobas Analyzer).
Preventive Care
Continuous risk monitoring to
Determine the risk of a future event
Aid the care provider (hospital and clinicians) on actionable decisions
Monitor trend of marker value to assess disease status
Enable real-time alert through EHR connectivity for intervention if needed
System Components
Our Platform’s System includes the following components:
Reader (wireless charger included)
Cartridge
Lancet (third party)
Software/App and EMR Connectivity)
Acute & Chronic Conditions Monitoring
Chronic conditions monitoring of diseases such as heart failure, rheumatoid arthritis & chronic kidney disease
Acute conditions monitoring of drug safety (such as drug induced liver injury) or adverse treatment response (such as Cytokine Release Syndrome (CRS) or Tumor Lysis Syndrome (TLS)
Non-invasive marker-based diagnosis




“I now appreciate how easy it would be monitoring my liver enzyme level from home on a regular basis, without having to make frequent visits to the hospital.”
— CHRISTINA., MULTIPLE SCLEROSIS PATIENT